Q-Vant Biosciences Announces Positive Study Results for Its Sustainable Quillaja-Based Vaccine Adjuvant, Q-VET-S®, in Kansas State’s Classic Swine Fever Vaccine
BOSTON, MA May 23, 2023 – Q-Vant Biosciences, the first company to achieve a 100% sustainable way to meet the growing global vaccine market...
Read more
Recent Comments